UB Researchers Propose A Novel Therapeutic Target For The Treatment Of Huntington Disease
An article published in The Journal of Biological Chemistry presents a novel pharmacological target that, in combination with a neurotrophic factor, could be used to improve the survival of striatal neurons, the principal nerve cells affected by the neurodegeneration observed in Huntington’s disease. The study was conducted by the researchers at the University of Barcelona. Huntington’s chorea is a progressive neurodegenerative disease caused by a genetic mutation of the gene encoding for the protein Huntingtin.
Read the full story here

